Cadila Healthcare Limited

Zydus Lifesciences Limited

Intas Pharmaceuticals Limited

Sanjay Jagdish Desai

Kumar Kamlesh Singh

Jayprakash Ajitsingh Parihar

Daya Ram Pal

Kuldeep Natwarlal Jain

Ramesh Chandra Singh

Piyush Rajendra Sharma

Alpesh Pravinchandra Shah

Mahesh Laljibhai Rupapara

Mettilda Lourdusamy

Ioan Iosif Radu

Sarvil Dhirajbhai Patel

Jitesh Amratlal Desai

Hemant Kumar Singh

Sanjeev Kumar Tripathi

Mayur Ramnikbhai Patel

Brijesh Dinkarrai Desai

Naitik Bharatbhai Patel

Dharmendra Arvindbhai Darji

Pramod Bhagvanjibhai Pansuriya

The present invention relates to a composition comprising high purity pyrrole derivative and method for preparation thereof. The present invention particularly relates to compositions comprising Saroglitazar magnesium having purity of 99.0% or more, and one or more of an aldehyde compound of Formula (II), diketo oxirane compound of Formula (III), hydroxy methyl compound of Formula (IV) or dimer compound of Formula (V), relative to saroglitazar magnesium, each present in an amount of about 0.15% or less, respectively, by weight, when measured by area percentage of HPLC.

Composition comprising high purity pyrrole derivative and method for preparation thereof

The invention relates to process for the preparation of isoxazoline-substituted benzamide compound and intermediates thereof. The invention also relates to process for the preparation of Fluralaner and intermediates thereof.

Process for preparation of isoxazoline substituted benzamide compound

The present invention relates to processes for the preparation of Filgotinib. The present invention relates to novel processes for the preparation of filgotinib. The present invention also relates to novel intermediates for the preparation of filgotinib.

Processes for the preparation of filgotinib

The present invention relates to compositions comprising saroglitazar magnesium wherein the saroglitazar magnesium has a purity of greater than or equal to 99% by weight, and dimer compound of Formula (IV) present in an amount relative to saroglitazar magnesium less than about 0.3% by weight by area percentage of HPLC. The present invention also related to the process for the preparation thereof and pharmaceutical compositions comprising the same.

Pyrrole compound, compositions and process for preparation thereof

The present invention relates to Brexpiprazole having a purity of about 99.5% or more by area percentage of HPLC, having total impurities not more than 0.5% relative to brexpiprazole as measured by area percentage of HPLC, and having less than 0.1% 1-(benzo[b]thiophen-4-yl)piperazine or a salt thereof relative to brexpiprazole by area percentage of HPLC. The present invention also provides a composition comprising brexpiprazole having 1-(benzo[b]thiophen-4-yl)-piperazine or a salt thereof in an amount less than about 0.1% relative to brexpiprazole by area percentage of HPLC and process for the preparation of brexpiprazole.

Process for the preparation of brexpiprazole and intermediates thereof

Dapagliflozin compounds and process for dapagliflozin preparation are described. Pharmaceutical compositions comprising dapagliflozin or solvates of dapagliflozin, for the treatment of diabetes are also described.

Process for the preparation of dapagliflozin

The present invention relates to an improved process for the preparation of Fulvestrant (I). Also, provided is novel intermediate of Fulvestrant and a process for the preparation of the same. 

Process for the preparation of fulvestrant

Growing community of inventors

Gujarat, India

Sanjay Jagdish Desai